Panacos Pharmaceuticals, Inc. (PANC) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Panacos Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.11
Burn Risk
P/B Ratio
0.15
Strong
WeakModerateStrong
Earnings Yield
-8.92%
Yield Gap
Profitability Health
2007Return on Equity
-129.75%
Weak
WeakModerateStrong
Operating Margin
21678.89%
Strong
WeakModerateStrong
Net Profit Margin
-20810.56%
Weak
WeakModerateStrong
Growth Indicators
2007Revenue Growth
-36.62%
Weak
WeakModerateStrong
Net Income Growth
1.71%
Weak
WeakModerateStrong
EPS Growth
6.67%
Weak
WeakModerateStrong
Efficiency & Liquidity
2007Current Ratio
5.47
Strong
WeakModerateStrong
Quick Ratio
5.47
Strong
WeakModerateStrong
Asset Turnover
0.00x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-7.40%
Weak
WeakModerateStrong
EV / Free Cash Flow
0.46x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.49x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-
No data
Return on Invested Capital
-
No data
Cash Conversion Cycle
298.08 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PANC.
View Financial Statements